Momentum continues to build in Congress to strengthen federal investment in biomedical research, with key House appropriations bills advancing funding increases for the National Institutes of Health (NIH) and critical lupus research priorities.
The House Appropriations Committee’s Fiscal Year 2027 Labor–HHS bill proposes $48.8 billion for NIH, including increases for institutes central to lupus research. This includes $6.6 billion for the National Institute of Allergy and Infectious Diseases (NIAID) and $685.5 million for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)—both representing meaningful increases above the Administration’s budget request.
Complementing these efforts, LRA joined dozens of leading organizations in a coalition letter to congressional leaders calling for increased NIH funding and greater transparency and stability in how research dollars are awarded and managed.
The full House of Representatives passed the FY27 Agriculture–FDA appropriations bill, which includes a provision supporting the FDA’s Lupus Accelerating Breakthroughs Consortium (Lupus ABC). This language underscores the success that Lupus ABC has already achieved in accelerating the development of lupus therapies.
Together, these actions signal strong bipartisan support for sustained investment in biomedical research and continued progress in lupus innovation. They also position lupus research priorities, including Lupus ABC, for inclusion in a final appropriations agreement later this year.
The Lupus Research Alliance will continue working with Congress, federal agencies, coalition partners, and LRA advocates to ensure these priorities are maintained and enacted into law, bringing us closer to safer, more effective treatments and ultimately a cure for lupus.
Tags: House Appropriations Committee’s Fiscal Year 2027 Labor–HHS bill, House of Representatives, Lupus ABC, Lupus Accelerating Breakthroughs ConsortiumU.S. Food and Drug Administration, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH